US states filed amended price-fixing claims against generic drugmakers
MLex Summary: More than 40 US states and territories filed amended price-fixing claims against generic drug manufacturers, including Teva, Pfizer and Actavis, accusing them of entering into illegal agreements that "have...To view the full article, register now.
Already a subscriber? Click here to view full article